Idiopathic pulmonary fibrosis trials in South Korea

In South Korea 11 Also abroad 111

11 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Bucheon-si, Incheon, Seongnam-si, Seoul, Songpa-dong
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Not yet taking people in South Korea
A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment
Where
Seoul
Age
40 years and over
People
70 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07926321 · EU 2026-527098-13-00
Phase 3Not yet taking people in South Korea
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Bucheon-si, Busan, Dong-gu, Ulsan, Goyang, Goyang-si, Haeundae-gu, Iksan, Kyunggi-do, Namdong-gu, Seoul, Suwon
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Seongnam-si, Seoul
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Where
Incheon, Seongnam-si, Seoul
Age
40 years and over
People
1,850 worldwide
Run by
United Therapeutics
See details and how to joinNCT04905693
Phase 2Taking people
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Where
Bucheon-si, Busan, Gwangju, Seoul, Suwon
Age
40 years and over
People
240 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Bucheon-si, Busan, Seongnam-si, Seoul
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00
Phase 3Taking people
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Where
Incheon, Seongnam-si, Seoul
Age
18 years and over
People
698 worldwide
Run by
United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00
Phase 2Taking people
SB17170 Phase 2 Trial in IPF Patients
Where
Goyang, Gwangmyeong, Seoul, Suwon
Age
40 years and over
People
30
Run by
SPARK Biopharma
See details and how to joinNCT06747923
No phaseTaking people
Korean Idiopathic Pulmonary Fibrosis Registry
Where
Seongnam-si
Age
30 years to 100 years
People
3,000
Run by
Seoul National University Hospital
See details and how to joinNCT04160715
No phaseTaking people
Controls for Respiratory Diseases
Where
Seoul
Age
19 years to 90 years
People
1,572
Run by
Seoul National University Hospital
See details and how to joinNCT03120481